Mortality and loss to follow-up among HAART initiators in rural South Africa

Transactions of the Royal Society of Tropical Medicine and Hygiene

Volumn 103, Issue 6, 2009, Pages 588-593

  MacPherson, Peter ^a   Moshabela, Mosa ^a   Martinson, Neil ^a,b   Pronyk, Paul ^a,c  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

HAART; HIV; Immune reconstitution inflammatory syndrome; Mortality; South Africa; Tuberculosis

Indexed keywords

ANTIRETROVIRUS AGENT;

ADULT; ARTICLE; CAUSE OF DEATH; COHORT ANALYSIS; DIARRHEA; FEMALE; FOLLOW UP; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREDICTION; RETROSPECTIVE STUDY; RURAL AREA; SOUTH AFRICA; TUBERCULOSIS;

ADULT; AIDS-RELATED OPPORTUNISTIC INFECTIONS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CAUSE OF DEATH; CD4 LYMPHOCYTE COUNT; COHORT STUDIES; FEMALE; HEALTH SERVICES ACCESSIBILITY; HIV INFECTIONS; HIV-1; HUMANS; MALE; PATIENT ACCEPTANCE OF HEALTH CARE; RETROSPECTIVE STUDIES; RURAL HEALTH; SOUTH AFRICA; TREATMENT OUTCOME; YOUNG ADULT;

EID: 67349087658     PISSN: 00359203     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trstmh.2008.10.001     Document Type: Article

References (28)

1. UNAIDS/WHO. AIDS epidemic update (2007), Joint United Nations Programme on HIV/AIDS and World Health Organization, Geneva
2. National Department of Health. HIV and AIDS and STI strategic plan for South Africa for 2007-2011 (2007), National Department of Health, Republic of South Africa, Pretoria
3. Lawn S.D., and Wood R. How can earlier entry of patients into antiretroviral programs in low-income countries be promoted?. Clin Infect Dis 42 (2006) 431-432
4. Lawn S.D., Myer L., Harling G., Orrell C., Bekker L.-G., and Wood R. Determinants of mortality and nondeath losses from an antiretroviral treatment service in South Africa: implications for program evaluation. Clin Infect Dis 43 (2006) 770-776
5. Rosen S., Fox M.P., and Gill C.J. Patient retention in antiretroviral therapy programs in sub-Saharan Africa: a systematic review. PLoS Med 4 (2007) e298
6. Mills E.J., Nachega J.B., Bangsberg D.R., Singh S., Rachlis B., Wu P., et al. Adherence to HAART: a systematic review of developed and developing nation patient-reported barriers and facilitators. PLoS Med 3 (2006) e438
7. Bedelu M., Ford N., Hilderbrand K., and Reuter H. Implementing antiretroviral therapy in rural communities: the Lusikisiki model of decentralized HIV/AIDS care. J Infect Dis 196 (2007) S464-S468
8. The Antiretroviral Therapy in Lower Income Countries (ART-LINC) Collaboration and ART Cohort Collaboration (ART-CC) groups. Mortality of HIV-1 infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries. Lancet 367 (2006) 817-824
9. Coetzee D., Hildebrand K., Boulle A., Maartens G., Louis F., Labatala V., et al. Outcomes after two years of providing antiretroviral treatment in Khayelitsha, South Africa. AIDS 18 (2004) 887-895
10. Etard J.F., Ndiaye I., Thierry-Mieg M., Guèye N.F., Guèye P.M., Lanièce I., et al. Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study. AIDS 20 (2006) 1181-1189
11. Jerene D., Endale A., Hailu Y., and Lindtjørn B. Predictors of early death in a cohort of Ethiopian patients treated with HAART. BMC Infect Dis 6 (2006) 136
12. Lawn S.D., Myer L., Orrell C., Bekker L.G., and Wood R. Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design. AIDS 19 (2005) 2141-2148
13. Stringer J.S., Zulu I., Levy J., Stringer E.M., Mwango A., Chi B., et al. Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes. JAMA 296 (2006) 782-793
14. Bekker L.G., Myer L., Orrell C., Lawn S., and Wood R. Rapid scale-up of a community-based HIV treatment service: programme performance over 3 consecutive years in Guguletu, South Africa. S Afr Med J 96 (2006) 315-320
15. Ivers L.C., Kendrick D., and Doucette K. Efficacy of antiretroviral therapy programs in resource-poor settings: a meta-analysis of the published literature. Clin Infect Dis 41 (2005) 217-224
16. Weidle P.J., Malamba S., Mwebaze R., Sozi C., Rukundo G., Downing R., et al. Assessment of a pilot antiretroviral drug therapy programme in Uganda: patients' response, survival, and drug resistance. Lancet 360 (2002) 34-40
17. Wester C.W., Kim S., Bussmann H., Avalos A., Ndwapi N., Peter T.F., et al. Initial response to highly active antiretroviral therapy in HIV-1C-infected adults in a public sector treatment program in Botswana. J Acquir Immune Defic Syndr 40 (2005) 336-343
18. Department of Local and Provincial Government. Bushbuckridge Nodal Development Profile. Pretoria: Department of Local and Provincial Government, Republic of South Africa; 2007.
19. Pronyk P.M., Kahn K., Hargreaves J.R., Tollman S.M., Collinson M., Hausler H.P., et al. Undiagnosed pulmonary tuberculosis deaths in rural South Africa. Int J Tuberc Lung Dis 8 (2004) 796-799
20. National Department of Health. National ARV Treatment Guidelines (2006), National Department of Health, Republic of South Africa, Pretoria
21. Kahn K., Tollman S., Garenne M., and Gear J. Validation and application of verbal autopsies in a rural area of South Africa. Trop Med Int Health 5 (2000) 824-831
22. Murdoch D.M., Venter W.D., Feldman C., and Van Rie A. Incidence and risk factors for the immune reconstitution inflammatory syndrome in HIV patients in South Africa: a prospective study. AIDS 22 (2008) 601-610
23. Badri M., Wilson D., and Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 359 (2002) 2059-2064
24. Lawn S., Myer L., Bekker L., and Wood R. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control. AIDS 20 (2006) 1605-1612
25. Lawn S., Harries A., Anglaret X., Myer L., and Wood R. Early mortality among adults accessing antiretroviral treatment programmes in sub-Saharan Africa. AIDS 22 (2008) 1897-1908
26. Martinson N.A., Karstaedt A., Venter W.D., Omar T., King P., Mbengo T., et al. Causes of death in hospitalized adults with a premortem diagnosis of tuberculosis: an autopsy study. AIDS 21 (2007) 2043-2050
27. Lawn S.D., Myer L., Bekker L.G., and Wood R. Tuberculosis-associated immune reconstitution disease: incidence, risk factors and impact in an antiretroviral treatment service in South Africa. AIDS 21 (2007) 335-341
28. Grant A.D., Charalambous S., Fielding K.L., Day J.H., Corbett E.L., Chaisson R.E., et al. Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment study. JAMA 293 (2005) 2719-2725